Friday, September 06, 2019 4:24:24 AM
Biosynthetic cannabinoid production eliminates the need for greenhouses and cultivation. The potentially disruptive technology involves using living cells like bacteria, algae or yeast to generate cannabinoids.
Alexandrian believes lab-created cannabinoids will be the future of the pharma industry, given the technology’s ability to produce a consistent active pharmaceutical ingredient. The technology is being closely studied by Organigram Inc. (OGI.TO)(OGI) and Cronos Group Inc. (CRON.TO)(CRON). Canopy Rivers is still looking at investment options.
https://finance.yahoo.com/news/canada-is-pretty-much-played-out-what-canopy-rivers-learned-from-thousands-of-pot-pitches-141549137.html
Wo: I’d just like to point out that there was an iHub poster on this board that predicted this a few years ago at the advent of this industry. MMPRuser. Although quite controversial most of the time, shared some very focused points on this board, many that have and might continue to come to pass. Hope he’s doing well.
Cheers.
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM